Berneis K - Search Results

1

Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR. Berneis K, et al. Metabolism. 2005 Feb;54(2):227-34. doi: 10.1016/j.metabol.2004.08.017. Metabolism. 2005. PMID: 15690318

2

Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome.

Kiencke S, Handschin R, von Dahlen R, Muser J, Brunner-Larocca HP, Schumann J, Felix B, Berneis K, Rickenbacher P. Kiencke S, et al. Among authors: berneis k. Eur J Heart Fail. 2010 Sep;12(9):951-7. doi: 10.1093/eurjhf/hfq110. Epub 2010 Jun 25. Eur J Heart Fail. 2010. PMID: 20581103 Free article.

3

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.

Berneis K, Rizzo M, Lazzarini V, Fruzzetti F, Carmina E. Berneis K, et al. J Clin Endocrinol Metab. 2007 Jan;92(1):186-9. doi: 10.1210/jc.2006-1705. Epub 2006 Oct 24. J Clin Endocrinol Metab. 2007. PMID: 17062762

4

Should we routinely measure low-density and high-density lipoprotein subclasses?

Rizzo M, Berneis K, Zeljkovic A, Vekic J. Rizzo M, et al. Among authors: berneis k. Clin Lab. 2009;55(11-12):421-9. Clin Lab. 2009. PMID: 20225664

5

Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size.

Krayenbuehl PA, Wiesli P, Schmid C, Lehmann R, Spinas GA, Berneis K. Krayenbuehl PA, et al. Among authors: berneis k. Swiss Med Wkly. 2008 May 3;138(19-20):275-80. doi: 10.4414/smw.2008.12124. Swiss Med Wkly. 2008. PMID: 18491240 Free article.

6

Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter.

Berneis K, Shames DM, Blanche PJ, La Belle M, Rizzo M, Krauss RM. Berneis K, et al. Metabolism. 2004 Apr;53(4):483-7. doi: 10.1016/j.metabol.2003.10.031. Metabolism. 2004. PMID: 15045696

7

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.

Berneis K, Rizzo M, Stettler C, Chappuis B, Braun M, Diem P, Christ ER. Berneis K, et al. Expert Opin Pharmacother. 2008 Feb;9(3):343-9. doi: 10.1517/14656566.9.3.343. Expert Opin Pharmacother. 2008. PMID: 18220486 Clinical Trial.

8

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.

Rizzo M, Spinas GA, Cesur M, Ozbalkan Z, Rini GB, Berneis K. Rizzo M, et al. Among authors: berneis k. Atherosclerosis. 2009 Dec;207(2):502-6. doi: 10.1016/j.atherosclerosis.2009.07.015. Epub 2009 Jul 8. Atherosclerosis. 2009. PMID: 19643412

9

Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.

Rizzo M, Trepp R, Berneis K, Christ ER. Rizzo M, et al. Among authors: berneis k. Eur J Endocrinol. 2007 Mar;156(3):361-7. doi: 10.1530/EJE-06-0652. Eur J Endocrinol. 2007. PMID: 17322496 Clinical Trial.

10

Small, dense low-density-lipoproteins and the metabolic syndrome.

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Diabetes Metab Res Rev. 2007 Jan;23(1):14-20. doi: 10.1002/dmrr.694. Diabetes Metab Res Rev. 2007. PMID: 17080469 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters